Oblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in Pediatrics

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT05656937
Collaborator
(none)
60
1
2
3.9
15.3

Study Details

Study Description

Brief Summary

this study aimed to compare oblique versus transverse orientation approach in jugular venous cannulation in term of cannulation success in pediatric heart surgery patients

Condition or Disease Intervention/Treatment Phase
  • Procedure: internal jugular venous cannulation
N/A

Detailed Description

Sixty patients randomised into two groups, 30 patients in experimental group (oblique orientation) and 30 patients in control group (transverse orientation). All cannulation took place in the operation room. Patients underwent general anesthesia and placed in supine position. Standard monitoring (electrocardiogram, non-invasive arterial pressure, pulseoxymetry) was carried out during the procedure for all patients. Before preparation of the skin, a pre-procedure ultrasound examination was performed to verify internal jugular vein patency, and its diameter was measured. Once the side had been chosen, the cannulation was performed following a sterile technique. All procedure were performed by Seldinger technique, with 22 Gauge IV catheter attached with 3 ml syringe as introducer needle. The vascular puncture was performed under ultrasound guidance, using a single-person technique. With transverse orientation, the transducer was placed transversally over the neck, and once the vein was visible in the middle of the ultrasound image, the needle was inserted in the plane perpendicular to the long axis of the transducer. With oblique orientation, the operator first obtained a transverse view of the vein and then rotated the transducer to 45 degrees (midway) between transverse and longitudinal view.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Oblique Versus Transverse Transducer Orientation Approach for Ultrasound Guided Internal Jugular Venous Cannulation in Heart Surgery Pediatric Patients
Actual Study Start Date :
Feb 1, 2021
Actual Primary Completion Date :
May 31, 2021
Actual Study Completion Date :
May 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Oblique orientation

cannulation will be oblique approach

Procedure: internal jugular venous cannulation
internal jugular venous cannulation

Active Comparator: transverse approach

cannulation will be transverse approach

Procedure: internal jugular venous cannulation
internal jugular venous cannulation

Outcome Measures

Primary Outcome Measures

  1. % of patients with successful cannulation in first attempt [at the procedure of cannulation]

    The number of patients undergo cannulation with first attempt success are shown in percentage

Secondary Outcome Measures

  1. % of patients with successful cannulation with designed approach [at the procedure of cannulation]

    The number of patients undergo cannulation using designed approach are shown in percentage

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients age 3 months to 12 years old, weight 5-20 kg, male or female

  • who undergo heart surgery and indicated to have central venous cannulation

  • American Society of Anesthesiologist Physical Class 1-3

  • Family or representation of the patients agreed to participate in this study and sign informed consent

Exclusion Criteria:
  • history of surgery in the area of cannulation

  • already placed central venous cannulation <72 hours in the same venous

  • sign of infection, hematoma, emphysema, in the area of cannulation

  • history of cervical trauma

  • severe hemostatic disorder (International Normalized Ratio>2, thrombocyte <50.000, Prothrombin time>1.5 times, Activated Partial Thromboplastin Time > 1.5 times

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Central National Hospital Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: aldy heriwardito, Doctor, Indonesia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aldy Heriwardito, Principal Investigator, Indonesia University
ClinicalTrials.gov Identifier:
NCT05656937
Other Study ID Numbers:
  • IndonesiaUAnes109
First Posted:
Dec 19, 2022
Last Update Posted:
Dec 19, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aldy Heriwardito, Principal Investigator, Indonesia University

Study Results

No Results Posted as of Dec 19, 2022